Save on Enjaymo with Coupons, Discounts & Savings Programs

Enjaymo is the brand name for sutimlimab-jome IV infusion.

Enjaymo is available as a 1,100 mg/22 mL (50 mg/mL) single-dose vial.

Enjaymo is a complement inhibitor that is used to treat cold agglutinin disease (CAD).

Enjaymo is a complement inhibitor. It works by attaching to certain proteins in your immune system. This prevents them from being activated so your immune system can’t attack your own red blood cells by mistake, which is what happens in CAD. This helps treat symptoms of CAD.

Enjaymo is typically dosed based on your weight:

• 85 lbs to less than 165 lbs: The typical dose is 6,500 mg injected into the veins (intravenous or IV) once per week for 2 weeks, then every 2 weeks thereafter
• 165 lbs or greater: The typical dose is 7,500 mg given IV once per week for 2 weeks, then every 2 weeks thereafter

Enjaymo is a safe and effective treatment when used for FDA licensed indications. However, like all medications, they may give you unwanted side effects. You should always discuss potential side effects with your physician to ensure the medication is suitable and right for you.

Common side effects of Enjaymo:

• Respiratory tract infection
• Viral infection
• Cough
• Joint pain
• Swelling in arms or legs
• Diarrhea
• Upset stomach

Serious side effects are rare with Enjaymo. Contact your healthcare provider immediately if you experience any of the following.

• Serious infections: fever, difficulty breathing, headache, weakness, confusion, sweating, chills, stiff neck, fast heart rate, muscle aches, diarrhea
• Severe allergic reaction: hives; swelling of the lips, tongue, or face; difficulty breathing; chest pain
• Infusion reaction: shortness of breath, fast heartbeat, flushing, headache, nausea

• There are no major drug interactions listed for Enjaymo. However, always let your physician and pharmacist know about any other medications or supplements (including prescribed and over-the-counter medications, vitamins, and dietary or herbal supplements) that you are currently taking

sanofi-aventis U.S.

It is not known if Enjaymo will harm your unborn baby. Tell your healthcare provider if you become pregnant while taking Enjaymo.

• Sutimlimab-JOME